DK255786A - Quinazolinderivater eller farmaceutisk acceptable salte eller estere deraf, deres fremstilling og anvendelse som farmaceutika - Google Patents

Quinazolinderivater eller farmaceutisk acceptable salte eller estere deraf, deres fremstilling og anvendelse som farmaceutika Download PDF

Info

Publication number
DK255786A
DK255786A DK255786A DK255786A DK255786A DK 255786 A DK255786 A DK 255786A DK 255786 A DK255786 A DK 255786A DK 255786 A DK255786 A DK 255786A DK 255786 A DK255786 A DK 255786A
Authority
DK
Denmark
Prior art keywords
group
heteroatom
quinazoline derivatives
pharmaceuticals
esters
Prior art date
Application number
DK255786A
Other languages
English (en)
Other versions
DK255786D0 (da
Inventor
Ann Lesley Jackman
David Richard Newell
Terence Richard Jones
Original Assignee
Nat Res Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Res Dev filed Critical Nat Res Dev
Publication of DK255786D0 publication Critical patent/DK255786D0/da
Publication of DK255786A publication Critical patent/DK255786A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88Oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK255786A 1985-05-31 1986-05-30 Quinazolinderivater eller farmaceutisk acceptable salte eller estere deraf, deres fremstilling og anvendelse som farmaceutika DK255786A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858513754A GB8513754D0 (en) 1985-05-31 1985-05-31 Anti-cancer quinazoline derivatives

Publications (2)

Publication Number Publication Date
DK255786D0 DK255786D0 (da) 1986-05-30
DK255786A true DK255786A (da) 1986-12-01

Family

ID=10579966

Family Applications (1)

Application Number Title Priority Date Filing Date
DK255786A DK255786A (da) 1985-05-31 1986-05-30 Quinazolinderivater eller farmaceutisk acceptable salte eller estere deraf, deres fremstilling og anvendelse som farmaceutika

Country Status (17)

Country Link
US (1) US5236927A (da)
EP (1) EP0204529B1 (da)
JP (1) JPS61282368A (da)
AT (1) ATE87621T1 (da)
AU (1) AU592271B2 (da)
DE (1) DE3688150T2 (da)
DK (1) DK255786A (da)
ES (1) ES8800911A1 (da)
FI (1) FI862303A7 (da)
GB (2) GB8513754D0 (da)
GR (1) GR861418B (da)
HU (1) HUT45512A (da)
IL (1) IL78910A0 (da)
NO (1) NO862170L (da)
NZ (1) NZ216363A (da)
PT (1) PT82682B (da)
ZA (1) ZA864051B (da)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607683D0 (en) * 1986-03-27 1986-04-30 Ici Plc Anti-tumor agents
GB8707053D0 (en) * 1987-03-25 1987-04-29 Ici Plc Anti-tumour agents
US4857530A (en) * 1987-11-03 1989-08-15 Warner-Lambert Company Substituted quinazolinones as anticancer agents
GB8809978D0 (en) * 1988-04-27 1988-06-02 Ici Plc Anti-tumour agents
EP0365763A1 (en) * 1988-09-30 1990-05-02 Agouron Pharmaceuticals, Inc. Antiproliferative cyclic compounds
US5286726A (en) * 1990-04-12 1994-02-15 The Regents Of The University Of Michigan Difluoroglutamic acid conjugates with folates and anti-folates for the treatment of neoplastic diseases
US6762188B1 (en) 1990-06-19 2004-07-13 Smithkline Beecham Corporation Pharmaceutically active benzoquinazoline compounds
GB9013615D0 (en) 1990-06-19 1990-08-08 Wellcome Found Pharmaceutical compounds
GB9105771D0 (en) * 1991-03-19 1991-05-01 Cancer Res Inst Royal Anti-cancer compounds
GB9205320D0 (en) * 1992-03-11 1992-04-22 Ici Plc Anti-tumour compounds
GB9205907D0 (en) * 1992-03-18 1992-04-29 Cancer Res Inst Royal Anti-cancer compounds
US5430148A (en) * 1992-03-31 1995-07-04 Agouron Pharmaceuticals, Inc. Antiproliferative quinazolines
GB9223352D0 (en) * 1992-11-06 1992-12-23 Ici Plc Tricyclic compounds
US7262058B2 (en) * 2001-03-09 2007-08-28 Nonda Katopodis Method for determining lipid associated sialoprotein in body fluids
RU2005115106A (ru) * 2002-10-18 2005-10-10 Конинклейке Филипс Электроникс Н.В. (Nl) Способ, система, устройство, сигнал и программный продукт для защиты метаданных в tv-anytime
US20060052345A1 (en) * 2002-11-04 2006-03-09 Nps Pharmaceuticals, Inc. Quinazolinone compounds as calcilytics
JP2009501235A (ja) * 2005-07-15 2009-01-15 シェーリング コーポレイション 癌処置において有用なキナゾリン誘導体
MX2008000744A (es) * 2005-07-15 2008-03-10 Schering Corp Derivados de quinazolina utiles en el tratamiento del cancer.
CA2663436A1 (en) 2006-10-04 2008-04-10 Pfizer Products Inc. Pyrido[4,3-d]pyrimidin-4(3h)-one derivatives as calcium receptor antagonists
EP2220050A2 (en) 2007-10-26 2010-08-25 The Regents Of The University Of California Diarylhydantoin compounds as androgen receptor modulators
ES3031438T3 (en) 2009-06-25 2025-07-08 Alkermes Pharma Ireland Ltd Heterocyclic compounds for the treatment of neurological and psychological disorders
AU2010339689B2 (en) * 2010-01-07 2015-02-19 Alkermes Pharma Ireland Limited Quaternary ammonium salt prodrugs
WO2011163594A2 (en) 2010-06-24 2011-12-29 Alkermes, Inc. Prodrugs of nh-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives
US9034867B2 (en) 2011-03-18 2015-05-19 Alkermes Pharma Ireland Limited Pharmaceutical compositions comprising sorbitan esters
JP6219918B2 (ja) 2012-03-19 2017-10-25 アルカームス ファーマ アイルランド リミテッド グリセロールエステルを含む医薬組成物
WO2013142198A1 (en) 2012-03-19 2013-09-26 Alkermes Pharma Ireland Limited Pharmaaceutical compositions comprising fatty acid esters
WO2013142205A1 (en) 2012-03-19 2013-09-26 Alkermes Pharma Ireland Limited Pharmaceutical compositions comprising benzyl alcohol
EP3718536A1 (en) 2012-09-19 2020-10-07 Alkermes Pharma Ireland Limited Pharmaceutical compositions having improved storage stability
EP3119399A4 (en) 2014-03-20 2017-09-27 Alkermes Pharma Ireland Limited Aripiprazole formulations having increased injection speeds
CA3092335A1 (en) 2018-03-05 2019-09-12 Alkermes Pharma Ireland Limited Aripiprazole dosing strategy
WO2024028999A1 (ja) * 2022-08-03 2024-02-08 Ils株式会社 N-[4-メチルアミノベンゾイル]-l-グルタミン酸ジエチルエステルの製造方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1021196A (en) * 1964-02-20 1966-03-02 Parke Davis & Co Novel amino acids and means for producing the same
US3471498A (en) * 1967-08-11 1969-10-07 Parke Davis & Co Certain n-p-((2,4-diamino-6-quinazolinyl)-methyl)benzoylamino acids
EP0031237B1 (en) * 1979-12-19 1984-10-17 National Research Development Corporation Quinazoline derivatives, processes for their preparation, compositions containing them and their use as anti-cancer agents
GB8607683D0 (en) * 1986-03-27 1986-04-30 Ici Plc Anti-tumor agents

Also Published As

Publication number Publication date
DE3688150T2 (de) 1993-07-29
GR861418B (en) 1986-09-26
EP0204529A2 (en) 1986-12-10
GB2175903B (en) 1988-10-12
FI862303A7 (fi) 1986-12-01
JPS61282368A (ja) 1986-12-12
AU5822086A (en) 1986-12-04
NZ216363A (en) 1989-07-27
US5236927A (en) 1993-08-17
GB8613184D0 (en) 1986-07-02
GB8513754D0 (en) 1985-07-03
DK255786D0 (da) 1986-05-30
HUT45512A (en) 1988-07-28
FI862303A0 (fi) 1986-05-30
DE3688150D1 (de) 1993-05-06
GB2175903A (en) 1986-12-10
EP0204529B1 (en) 1993-03-31
ES8800911A1 (es) 1987-12-01
NO862170L (no) 1986-12-01
IL78910A0 (en) 1986-09-30
ATE87621T1 (de) 1993-04-15
ZA864051B (en) 1987-01-28
PT82682A (en) 1986-06-01
EP0204529A3 (en) 1987-11-19
PT82682B (pt) 1988-03-03
AU592271B2 (en) 1990-01-04
ES555548A0 (es) 1987-12-01

Similar Documents

Publication Publication Date Title
DK255786D0 (da) Quinazolinderivater eller farmaceutisk acceptable salte eller estere deraf, deres fremstilling og anvendelse som farmaceutika
ES8300716A1 (es) Procedimiento para preparar derivados de 2-amino-4-hidroxi- quinazolina
PT91121A (pt) Processo para a preparacao de derivados da quinolina e de composicoes farmaceuticas que os contem
MX171822B (es) Proceso quimico
ES8704938A1 (es) Procedimiento para preparar nuevos derivados aminicos heteroaromaticos
DK114783A (da) Hidtil ukendte forbindelser, fremgangsmaader til deres fremstilling samt deres anvendelse som laegemidler
DK37189D0 (da) Substituerede quinoliner og cinnoliner, fremgangsmaader til deres fremstilling samt deres anvendelse
PT82854B (pt) Processo para a preparacao de derivados do acido piridono-carboxilico
FR2526659B1 (fr) Medicaments immunomodulants a base de derives de l'acide phenylacetique
AR241422A1 (es) Procedimiento para la preparacion de derivados de difenil(metil-etil-0 etenil) piperidinas.
DE3665711D1 (de) Novel guanidinomethylbenzoic acid derivatives
DK529585A (da) N-(6-methoxy-5-(perflouralkyl)-1-naphtholyl)-n-methylglyciner og deres thionaphthoyl analoge, deres fremstilling og anvendelse som laegemidler
PT89757A (pt) Processo para a preparacao de novos derivados da xantina e de composicoes farmaceuticas que os contem, uteis no tratamento da ulcera peptica
ES550971A0 (es) Un procedimiento para la preparacion de nuevos derivados de esteres fosforicos.
PT83975B (pt) Processo para a preparacao de derivados de 5-aminoalquil-beta-carbolinas e de composicoes farmaceuticas que os contem
DK614989D0 (da) Indolderivater, fremgangsmaade til deres fremstilling og farmaceutiske midler indeholdende dem
ATE87307T1 (de) Isoindolinderivate und verfahren zu ihrer herstellung.
ES2003758A6 (es) Procedimiento para preparar nuevos derivados de acidos fenilaceticos
ATE144900T1 (de) Verwendung von xanthinderivaten gegen magengeschwüre
ES2045335T3 (es) Un procedimiento para la preparacion de nuevas s-difluorometilhomocisteinas.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment